Clinical Trials Browser

Phase 2 × Acquired Immunodeficiency Syndrome × 1 year × Clear all

Squamous Cell Carcinoma of Head and Neck, Acquired Immunodeficiency Syndrome, Anus Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Neoplasms, Vulvar Neoplasms

NCT00006436 2025-12-30

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

Phase 2 Completed

68 enrolled 24 charts

Lymphoid

Acquired Immunodeficiency Syndrome, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related

NCT06519994 2025-12-17

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Phase 2 Active not recruiting

120 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT02479698 2025-11-18

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Phase 2 Recruiting

100 enrolled

Dermatologic

Acquired Immunodeficiency Syndrome, Neoplasms, Carcinoma, Merkel Cell, Encephalitis, Viral

NCT07090174 2025-10-01

Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

Phase 2 Not yet recruiting

27 enrolled

GastrointestinalGynecologic

Acquired Immunodeficiency Syndrome, Anus Neoplasms, Uterine Cervical Neoplasms

Clinical Trials

Potlako+

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV